Expert insights, guides, and stories about health 
The promise of artificial intelligence in healthcare is immense, yet its rapid deployment has unearthed a critical need for robust risk assessment frameworks. As investors…
The burgeoning promise of artificial intelligence in healthcare is consistently tempered by critical questions of accuracy, reliability, and ultimately, patient safety. As general-purpose AI models…
The collapse of Babylon Health in 2023, once valued at $4.2 billion, with its UK assets eventually sold for £500,000, serves as a stark reminder…
The healthcare artificial intelligence landscape, brimming with promise and investment, has also become a graveyard for ventures that prioritized hype over evidence. The cautionary tales…
The promise of artificial intelligence in healthcare is vast, yet the chasm between general-purpose AI and clinically validated solutions remains dangerously wide. A critical incident,…
The narrative of AI in healthcare is often painted with broad strokes of transformative potential, yet the critical examination of clinical evidence frequently lags behind…
The saga of Pear Therapeutics, once a beacon for digital therapeutics, offers a stark, cautionary tale for investors and regulators alike: FDA clearance, while critical,…
The cautionary tale of Theranos, culminating in a belated FDA warning letter, offers a stark blueprint for the critical need to proactively address AI safety…
The recent dual enforcement action against Cerebral by the Department of Justice (DOJ) and the Federal Trade Commission (FTC), which included a $10 million civil…
The promise of artificial intelligence in healthcare is transformative, yet a sobering reality exists beneath the hype: a graveyard of once-lauded companies, collectively representing over…
The promise of artificial intelligence in healthcare is transformative, yet the landscape is littered with cautionary tales, stark reminders that innovation without robust validation can…
The echoes of Theranos’ spectacular collapse still reverberate through healthcare, a stark reminder of the perils of hype over evidence. Yet, the investment community continues…
The Federal Trade Commission’s (FTC) recent $7.8 million fine against BetterHelp represents a watershed moment, not just for digital mental health platforms, but for the…
The recent genetic data breach at 23andMe serves as a stark, urgent reminder for health system CIOs and patient safety advocates: in the realm of…
The intersection of digital health and patient privacy has been thrust into sharp relief by a series of lawsuits targeting hospital systems for their use…
The promise of artificial intelligence in healthcare is often framed through lenses of efficiency and precision, yet a critical, often overlooked, dimension is its potential…
The promise of artificial intelligence in healthcare is often framed by its potential to revolutionize diagnostics, personalize treatment, and enhance patient outcomes. Yet, a critical…
The specter of Teladoc Health’s $13.7 billion Livongo write-down looms large over the digital health landscape, a stark reminder that even multi-billion-dollar acquisitions can unravel…
The narrative of AI in healthcare is often painted with broad strokes of transformative potential, promising unparalleled efficiencies and diagnostic precision. Yet, the spectacular rise…
The spectacular collapse of Babylon Health, once valued at $4.2 billion, serves as a stark reminder to investors and health system CIOs alike: the promise…
